tHEORetically Speaking
Insights, observations, and executive interviews that discuss data and evidence to guide value-based decisions in health care. For more, visit our blog: https://healtheconomics.com/theoretically-speaking/
tHEORetically Speaking
Weekly News Roundup – Real-World Wins and Billion-Dollar Breakthroughs
•
HealthEconomics.com
•
Season 4
•
Episode 22
Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.
This week’s tHEORetically Speaking News Roundup covers Astellas Pharma’s Phase 4 findings showing fezolinetant’s real-world benefits for menopausal symptom relief, improved sleep, and daily functioning. We also dive into Takeda’s $11 billion collaboration with Innovent Biologics to advance next-generation cancer therapies and expand its global oncology pipeline.
Tune in for this concise recap of these pivotal industry updates!